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15Objective: Previous studies testing the hypothesis that
symptoms of anxiety and depression increase blood
pressure (BP) levels show inconsistent and limited findings.
We examined the association between those symptoms
across adult life and BP in late middle age.
Methods: Using data from 1683 participants from the
MRC NSHD, we investigated associations between
affective symptoms at ages 36, 43, 53 and 60–64 years
and SBP and DBP at age 60–64. Multivariable linear
regression was used to examine the effect on BP of
affective symptoms at each age separately and as a
categorical cumulative score based on the number of times
an individual was classified as a ‘case’. Models were
adjusted for sex, BMI, educational attainment, socio-
economic position, heart rate, lifestyle factors and
antihypertensive treatment.
Results: In fully adjusted models, we observed lower SBP
in study members with case-level symptoms at one to two
time-points [1.83mmHg; 95% confidence interval (CI)
3.74 to 0.01] and at three to four time-points
(3.93mmHg; 95% CI 7.19 to 0.68) compared with
those never meeting case criteria suggesting a cumulative
inverse impact of affective symptoms on SBP across
adulthood (P value for trend 0.022). Sex and BMI had a
large impact on the estimates while not other confounders.
Potential mediators such as heart rate and lifestyle
behaviours had a little impact on the association. SBP at age
36 and behavioural changes across adulthood, as additional
covariates, had a little impact on the association. A similar
but weaker trend was observed for DBP.
Conclusion: A cumulative effect of symptoms of anxiety
and depression across adulthood results in lower SBP in
late middle age that is not explained by lifestyle factors
and antihypertensive treatment. Mechanisms by which
mood may impact BP should be investigated.
Keywords: blood pressure, epidemiology, longitudinal
studies, population, repeated measures, symptoms of
anxiety and depression
Abbreviations: ACTH, adrenocorticotropic hormone; BNF,
British National Formulary; BP, blood pressure; CI,
confidence interval; CRH, corticotrophin-releasing-factor;Copyright © Lippincott Williams & Wilkins. Unaut
90 www.jhypertension.comGHQ, General Health Questionnaire; HPA, hypothalamic-
pituitary-adrenal; MRC NSHD, Medical Research Council
National Survey of Health and Development; PSE, Present
State Examination; PSE-ID, index of definition; PSF,
Psychiatric Symptom Frequency scaleINTRODUCTIONT
hehypothesis that symptoms of anxiety and depres-
sion affect long-term blood pressure (BP) regulation
was postulated in the early 20th Century [1]. This
association has been investigated in several cross-sectional
studies, but conflicting evidence emerged [2–7]. The lack of
appropriate prospective data has long been perceived as a
critical flaw. However, in the last decade, findings from
longitudinal studies became available [8–13], although
conflicting results remained. As summarized in a recent
meta-analysis [14], the methodological protocols across
studies vary tremendously with regard to the length of
follow-up, sample size, age, sex and ethnic composition,
psychological measures, definition of hypertension (e.g.
140/90, 165/95mmHg or self-reported hypertension)
and appropriate control for potential mediators and con-
founders. Although some longitudinal studies found a
positive association between depressive symptoms and
hypertension [10–13,15], others reported no such associ-
ation [16–19] or found an inverse association [8,9,20]. Mosthorized reproduction of this article is prohibited.
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Blood pressure and depression across adulthoodof these reports have typically focused on incident hyper-
tension as an outcome [10–13,15,17–20] rather than on BP
as continuous trait [8,9,16,21]. To date, few studies have
examined the longitudinal association between symptoms
of anxiety and depression and BP levels.
In the present study, we investigated the effect of
repeated measures of symptoms of anxiety and depression
collected through 24 years on BP levels at age 60–64 within
a British community-based population. We also tested
whether there were cumulative effects of those symptoms
on BP levels while accounting for a large number of
potential confounders and mediators.
MATERIALS ANDMETHODS
Study members
TheMedical ResearchCouncil National Survey ofHealth and
Development (NSHD) is a socially stratified sample of 5362
singleton births that took place in 1 week of March 1946 in
England, Scotland and Wales [22]. This cohort has been
followed up prospectively 23 times, from birth onwards.
The main data collections in adult life were at 26, 36, 43 and
53 years. Between 2006 and 2010 (at 60–64 years), 2856
eligible study members (those known to be alive and with a
known address in England, Scotland or Wales) were invited
for an assessment at one of six clinical research facilities or to
be visited by a research nurse at home. Invitations were not
sent to those who had died (n¼ 778), who were living
abroad (n¼ 584), had previously withdrawn from the study
(n¼ 594) or had been lost to follow-up (n¼ 550) [23]. Of
those invited, 2229 (78%) were assessed: 1690 (59.2%)
attended a clinical research facility and the remaining 539
were seenat home.A total of 2216 studymembershadat least
one valid outcome measured. Of those 627 not assessed, 31
haddied, 356 refused toparticipate and240completedonly a
postal questionnaire. Ethical approval for the study was
obtained from the Greater Manchester Local Research Ethics
Committee and the Scotland Research Ethics Committee.
Written, informed consent was obtained from study mem-
bers for each component of the data collection. From the
current respondents, a total of 1683 study members had
nonmissing data for all variables incorporated in these
analyses.
Assessments of symptoms of depression and
anxiety
Symptoms of anxiety and depression were assessed at age
36 by a short version of the Present State Examination (PSE)
[24], a clinically validated interview administrated by trained
nurses assessing the frequency and severity of neurotic and
affective symptoms in the preceding month. For case-level
anxiety and depression symptoms, the index of definition
(PSE-ID) provides a scale of severity ranging from 1 to 7,
with a threshold for caseness of 5 or more [25]. At age 43
years, the Psychiatric Symptom Frequency scale (PSF) [26],
an interview-based 20-item scale that rates the frequency
and severity of neurotic and affective symptoms in the 12
preceding months was administered. The total score on the
PSF scale was calculated by adding the scores of the first 18
items of the instrument, with a threshold for potential
caseness between 22 and 23 [26]. At ages 53 and 60–64Copyright © Lippincott Williams & Wilkins. Unauth
Journal of Hypertensionyears, study members completed the 28-item General
Health Questionnaire (GHQ) [27], a self-administered ques-
tionnaire focusing on the experience and psychosocial
impact of symptoms of anxiety and depression in the
preceding month. This questionnaire correlates highly with
the PSE [28]. Each item was coded according to Likert
scoring (0–1–2–3) and further coded as 0 for response
choices 0 and 1 and as 1 for response choices 2 and 3.
Caseness was defined as a total score equal to or greater
than 5 when these items were recoded to 0–0–1–1 [29].
Assessment of blood pressure and
hypertension
At each assessment, BP was measured twice by a trained
nurse in the participant’s home or at one of the clinical
research facilities, while the survey member was seated and
after 5min rest. An average of two consecutive readings was
calculated, unless only one reading was available, in which
case this was used instead (<1% of all observations). At ages
36 and 43 years, a Hawksley random zero sphygmoman-
ometer was used, and at ages 53 and 60–64 years, an
automated digital oscillometric sphygmomanometer
(Omron HEM-705; Omron Corp., Tokyo, Japan) was used.
Corrections for the machine switch in the last wave using
published conversion equations [30,31] made no difference
to the results, and so we present the results using the
uncorrected values. All readings were taken using an
appropriate cuff size for arm circumference. We defined
hypertension as the mean SBP of 140mmHg or higher, or as
the mean DBP of 90mmHg or higher, or current use of
antihypertensive medications. At each assessment, study
members were asked whether they had taken any pre-
scribed medication or tablets for high BP in the last year.
Antihypertensive medications included drug listed in the
British National Formulary (BNF) in section 2.2 (diuretics),
2.4 (b blockers), 2.5 (Hypertension and heart failure) and
2.6.2 (calcium channel blockers) [32].
Covariates
Factors that could confound or mediate the main associ-
ations were identified a priori. The highest educational
qualification achieved by age 26 years was dichotomized
into those with advanced (’A level’, taken during the final
year of secondary/high school) or higher (university or
equivalent) qualifications, versus those below this level.
Socio-economic position at age 53 was used as an indicator
of main occupation in adulthood and categorized using the
Registrar General’s Social Classification into two groups:
nonmanual skill (I or II or IIINM) and manual skill (IIIM or
IV or V). In addition, the following covariates at age 36, 43,
53 and 60–64 years were used as potential mediators. Data
on lifestyle behaviours were extracted from questionnaires,
interview-based prospective information and diet diaries.
At each interview waves, study members who provided an
affirmative response to being current cigarette smokers,
regardless of the quantity of cigarettes smoked per day,
were classified as ‘smokers’, whereas those who provided a
negative response were classified as ‘nonsmoker’. From the
type and number of alcoholic drinks, we calculated alcohol
consumption in grams per day. To exclude occasional
drinkers, we distinguished drinkers from nondrinkers onorized reproduction of this article is prohibited.
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activity levels were ascertained at ages 36, 43 and 53 years
during interviews with nurses at the study participants’
homes. Different measures for leisure-time physical activity
were included in the surveys administered at the respective
ages. Full description of those specific ascertainments was
extensively described elsewhere [33,34]. At each age,
participants were categorized as physically inactive (no
participation or participation in relevant activities one to
four times in the previous 4weeks) or active (participated in
relevant activities five or more times in the previous 4
week).
Lifetime behaviour status was constructed from the four
interview waves for smoking, drinking and physical activity
for participants with information on at least three of the four
data collections. For lifetime smoking status, the study
members were classified into one of four trajectories: ‘Never
smoker’ (a nonsmoker at all available data collections),
‘Predominantly nonsmoker’ (a nonsmoker for at least
two data collections), ‘Predominantly smoker’ (a smoker
for at least three data collections), ‘Lifelong smoker’
(a smoker at all available data collections). In cases wherein
data were missing from one waves, classification was based
on the status at the majority of data collections. Thus, if at
two of three data collections the cohort members reported
being a smoker, then they were classified as predominantly
smokers. This behaviour was then categorized into two
trajectories: never smoker (i.e. a never smoker or predom-
inantly nonsmoker) and ever smoker (i.e. a predominantly
smoker or lifelong smoker). The same approach in coding
was used for lifetime drinking status (never drinker and
ever drinker) and for physically active status (never active
and ever active).
BMI was calculated as weight in kilograms divided by
height in meters squared, derived from height and weight
measured at ages 36 and 60–64 years without shoes with
study members wearing light indoor clothing by research
nurses during the home visit. Change in mean BMI was
calculated as the difference between BMI at age 60–64 and
BMI at age 36.
While the study member was seated and after 5min rest,
at age 36, resting heart rate at the wrist (beats/min) was
counted for 1min. At age 60–64, heart rate was measured
by the automated digital oscillometric sphygmomanome-
ter. Change in mean heart rate was calculated as the
difference between heart rate at age 60–64 and heart rate
at age 36.
Diabetes mellitus at age 60–64, coded as a binary vari-
able, was a self-reported diagnosis, or a fasting blood
glucose concentration of at least 7.0mmol/l, or glycated
haemoglobin of at least 6.5%, or use of insulin or oral
antidiabetic agents. History of cardiovascular disease
(CVD) self-reported at age 60–64, coded as a binary var-
iable, included nonfatal myocardial infarction, acute cor-
onary syndrome, surgical and percutaneous coronary
revascularization, angina pectoris, chronic ischemic heart
disease, stroke and heart failure.
Treatment with antidepressant medications was coded at
ages 36, 43, 53 and 60–64. Antidepressant medications
included any drug listed in the BNF section 4.3 (tricyclic
antidepressants, monoamine-oxidase inhibitors, selectiveCopyright © Lippincott Williams & Wilkins. Unaut
1592 www.jhypertension.comserotonin reuptake inhibitors and other antidepressant
drugs) [32].
Statistical methods
We used x2 and one-way analysis of variance (ANOVA) to
examine differences in characteristics across groups of
lifetime symptoms of anxiety and depression status.
Multivariable linear regression models were used to
test the association between symptoms of anxiety and
depression (case versus noncase) at each age and BP
levels (systolic and diastolic in separate models) at age
60–64 years, initially unadjusted (model 1) then adjusted
for the two confounders sex and BMI at 60–64 years
(model 2). Formal tests of gender by symptoms of anxiety
and depression interaction were performed in model 2 and
no evidence of this was found. Further adjustments were
then made for the confounders educational attainment and
socio-economic position (model 3). Potential mediators
such as heart rate, smoking status, drinking status and
physical activity at age 60–64 and confounder such as
antihypertensive treatment at age 60–64 were also added
(model 4). Finally, the two confounders’ history of CVD
and diabetes mellitus status at age 60–64 were included
(model 5).
We then tested whether there was evidence of a cumu-
lative effect of symptoms of anxiety and depression across
adulthood by creating a lifetime anxiety and depression
caseness variable based on the number of times an indi-
vidual was classified as a ‘case’ during the follow-up: never
meeting affective symptom case criteria, case-level symp-
toms at one to two time-points and case-level symptoms at
three to four time-points. Associations between lifetime
affective caseness (categorized into three groups) and each
BP outcome (SBP and DBP) were tested with adjustments
for the same covariates as above. The analyses presented
are based on the sample with complete data on symptoms
of anxiety and depression at all four ages, all covariates and
at least one of the outcome measures (n¼ 1683).
Logistic regression analysis with adjustments for the
same covariates as above was conducted to determine
whether the lifetime symptoms of anxiety and depression
status was a potential predictor for hypertension at age
60–64.
Linear regression analyses were also rerun with adjust-
ments for SBP at age 36 years (starting from model 3); with
adjustments for behavioural changes across adulthood
(including in model 2 change in mean BMI between ages
36 and 60–64 years and in model 4 change in mean heart
rate between age 60–64 and 36 years, lifetime smoking
status, lifetime drinking status, lifetime physical activity
status); with adjustments for antidepressant medications
at age 60–64; incorporating the use of antidepressant
medications into the definition of symptoms of anxiety
and depression; excluding participants using antihyperten-
sive medications; and introducing a correction of BP value
for study members on hypertensive medication by adding
10mmHg to SBP and 5mmHg to DBP in accordance with
Cui et al. [35] and based on the efficacy of antihypertensive
drugs in randomized trials [36]. Antihypertensive treatment
was excluded as a covariate from Models 4 and 5. There
were no differences in findings.horized reproduction of this article is prohibited.
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Blood pressure and depression across adulthoodFor statistical analysis, we used SAS software, version 9.3
(SAS Institute, Cary, North Carolina, USA). P value less than
0.05 (two-tailed) was considered statistically significant.
RESULTS
Characteristics of participants
Table 1 presents the general characteristics of the 1683
study members (52.4% women) at age 60–64 by lifetime
symptoms of anxiety and depression status. The number of
study members never meeting affective symptom case
criteria over the course of the study was 1080 (64.2%);
the number who reported case-level symptoms at one to
two time-points was 474 (28.1%); and at three to four time-
points, this was 129 (7.7%). There were significant
between-group differences. Study members who reported
case-level symptoms at three to four time-points compared
with those never meeting case criteria were more likely to
be female, to have lower SBP and DBP, to have higher BMI
and lower education level, to be smokers, nondrinkers and
physically inactive, to be treated for hypertension, to be
diabetic, to have a prevalent history of CVD and to be
treated with antidepressant drugs. No between-group
differences at the 5% level were observed for heart rate,
socio-economic position and prevalence of hypertension.
Symptoms of anxiety and depression across
follow-up time points
In unadjusted models, caseness affective symptoms at ages
43, 53 and 60–64 were inversely associated with SBP at age
60–64 (supplementary Table 1, http://links.lww.com/HJH/
A361). There was no evidence at ages 43, 53 and 60–64 that
these associations differed by sex (P¼ 0.47, 0.49 and 0.64
from tests of sex interaction, respectively). However,
adjustment for the confounders sex and BMI at ageCopyright © Lippincott Williams & Wilkins. Unauth
TABLE 1. Characteristics of the study participants at age 60–64 by lif
Characteristics at 60–64 years
All individuals
(n¼1683)
Never meeti
case-criteri
(n¼1080)
Sex (women), n % 883 (52.4) 499 (46.2)
Clinical features
SBP (mmHg)a 136.218.0 137.318.3
DBP (mmHg)a 77.89.8 78.39.7
Heart rate (bpm) 68.611.0 68.611.2
BMI (kg/m2)b 28.04.9 27.84.6
Questionnaire data
Educational attainment by age 26
(higher level), n (%)
682 (40.5) 445 (41.2)
Socioeconomic position at age 53
(nonmanual skill), n (%)
1134 (67.4) 726 (67.2)
Smokers (current), n (%) 190 (11.3) 96 (8.9)
Drinkers (5g/day), n (%) 1067 (63.4) 882 (76.1)
Leisure-time physical activity
(inactive), n (%)
1059 (63.0) 653 (60.5)
Hypertension, n (%) 982 (58.4) 629 (58.2)
Antihypertensive treatment, n (%) 562 (33.4) 331 (30.6)
Diabetes mellitus, n (%) 164 (9.7) 100 (9.3)
History of cardiovascular disease,
n (%)
131 (7.8) 110 (10.2)
Antidepressant treatment, n (%) 130 (7.7) 44 (4.1)
Values are arithmetic means SD or number of individuals (%).
aAverage of two blood pressure readings obtained at clinic or at home visit.
bThe BMI is weight in kilograms divided by the square of the height in meters.
Journal of Hypertension60–64 (model 2) attenuated those associations. The other
confounders (education at age 26, socio-economic position
at age 53 and antihypertensive treatment, history of CVD
and diabetes at age 60–64) and potential mediators (heart
rate, smoking, drinking and physical inactive status at age
60–64) had a little impact. In fully adjusted models, a
borderline inverse association between caseness of symp-
toms of anxiety and depression at age 43 and SBP remained
[2.71mmHg: 95% confidence interval (CI) 5.47 to 0.06],
whereas at ages 53 and 60–64, the inverse associations
were not statistically significant (1.97mmHg; 95% CI
4.14 to 0.18; and 1.72mmHg; 95% CI 3.94 to 0.49,
respectively). No association between caseness of symp-
toms of anxiety and depression at age 36 and SBP at age
60–64 was found.
For DBP at age 60–64, in unadjusted models, we
observed inverse associations with caseness affective symp-
toms at ages 53 and 60–64 years (data not shown). How-
ever, adjustment for the confounders sex and BMI at age
60–64 strongly attenuated those associations. No associ-
ations between caseness of anxiety and depression at ages
36 and 43 years and DBP at age 60–64 were found.
Lifetime anxiety and depression caseness
Across follow-up, there were differences in SBP means by
lifetime anxiety and depression caseness (Fig. 1). The
differences in means between age 53 and age 36 were
16.4mmHg for SBP (P< 0.0001) and 7.8mmHg for DBP
(P< 0.0001). No difference in mean was observed between
age 53 and age 60–64 for SBP (P¼ 0.63), whereas mean
DBP at age 53 was lower by 6.3mmHg than at age 60–64
(P< 0.0001).
In Table 2, the unadjusted model (model 1) showed that
study members reporting case-level affective symptoms at
one to two time-points had lower SBP at age 60–64 thanorized reproduction of this article is prohibited.
etime anxiety and depression caseness (n¼1683)
ng
a
Case-level symptoms
at 1–2 time-points
(n¼474)
Case-level symptoms at
3 to 4 time-points
(n¼129) P trend
286 (60.3) 98 (76.0) <0.0001
134.817.8 132.016.0 0.001
76.99.9 76.49.2 0.009
68.510.7 68.710.4 0.97
28.25.3 28.95.7 0.04
202 (42.6) 35 (27.1) 0.005
327 (69.0) 81 (62.8) 0.40
71 (15.0) 23 (17.8) 0.0001
346 (73.0) 76 (58.9) 0.0001
305 (64.3) 101 (78.3) 0.0003
275 (58.0) 78 (60.5) 0.87
181 (38.2) 50 (38.8) 0.006
43 (9.1) 21 (16.3) 0.03
77 (16.2) 25 (19.4) 0.002
58 (12.2) 28 (21.7) <0.0001
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Tikhonoff et al.those never meeting case criteria (2.46mmHg; 95% CI
4.39 to 0.52), as well as study members meeting criteria
at three to four time-points (5.36mmHg; 95% CI: 8.62 to
2.07) (P-value for trend 0.001). In model 2, sex and BMI at
age 60–64 acted as strong confounders and partially atte-
nuated those associations. Models 3, 4 and 5 showed that
the other confounders (education at age 26, socio-
economic position at age 53 and antihypertensive treat-
ment, history of CVD and diabetes at age 60–64) and
potential mediators (heart rate, smoking, drinking and
physical inactive status at age 60–64) had a little impact.
Therefore, after full covariate adjustment, we observed a
clear inverse dose–response for lower SBP in relation to
frequency of affective caseness [case-level symptoms at one
to two time-points: 1.83mmHg (95% CI 3.74 to 0.01);
and at three to four time-points: 3.93mmHg (95% CI
7.19 to 0.68) compared to those never meeting case-
criteria] suggesting a cumulative impact of anxiety and
depression on SBP across adulthood (P value for trend
0.022).
A similar but weaker negative association was observed
for DBP (supplementary Table 2, http://links.lww.com/
HJH/A361). In the unadjusted model, study members with
case-level symptoms at one to two time-points had lower
DBP than those never meeting case-criteria (1.40mmHg;
95% CI 2.46 to 0.35); for case-level at three to four time-
points, this was 1.93mmHg (95% CI 3.71 to 0.15) (P-
value for trend 0.01). These associations were significantly
attenuated after adjustment for sex and BMI and less atte-
nuated after adjustment for the other confounders and
mediators (0.88 and 0.75mmHg, respectively; P value
for trend 0.22).
Lifetime anxiety and depression caseness and
hypertension risk
In unadjusted logistic regression analysis, study members
with case-level affective symptoms at one to two time-
points and at three to four time-points were not more likelyCopyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
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Blood pressure and depression across adulthoodto be hypertensive than those never meeting case criteria
[odds ratio (OR) 0.96; 95% CI 0.77–1.20 andOR 1.10; 95% CI
0.75–1.60, respectively] (P value for trend 0.83). This was
confirmed in a fully adjusted model considering all cova-
riates except antihypertensive treatment (OR 0.98; 95% CI
0.77–1.24 and OR 0.96; 95% CI 0.63–1.45, respectively)
(P value for trend 0.97).
Sensitivity analysis
To test the robustness of our findings, we undertook several
sensitivity analyses.
First, in our main analysis, we considered SBP at age
36 years as an additional covariate in order to evaluate the
potential confounding effect of baseline BP value. In
supplementary Table 3, http://links.lww.com/HJH/A361,
Model 3 shows that SBP at age 36 had a little impact. In
the fully adjusted model, the inverse association between
lifetime anxiety and depression caseness and SBP at age
60–64 years [3.34mmHg (95% CI 6.53 to 0.16)] was
only slightly attenuated (P¼ 0.07).
Second, we considered adjustments for behavioural
changes across adulthood. The sample for this analysis
comprised those who provided data for at least three of
the four data collections (n¼ 1660). Study members with
case-level symptoms at three to four time-points (n¼ 123)
than those never meeting case criteria (n¼ 1070) were
more likely to be smokers overtime (22.8 versus 12.5%,
P¼ 0.003), nondrinkers overtime (58.5 versus 44.9%,
P¼ 0.01), to be physically inactive overtime (69.9 versus
54.0%, P¼ 0.0003) and to have higher BMI change overtime
(þ4.80 versus þ3.87 kg/m2, P¼ 0.003). No between-group
differences at the 5% level were observed for change in
heart rate. In study members with case-level symptoms at
three to four time-points, the unadjusted inverse association
between lifetime anxiety and depression caseness and SBP
[5.02mmHg (95% CI 8.34 to 1.69)] was attenuated
once adjusted by sex and change in BMI between ages
60–64 and 36 years [3.47 (95% CI 6.76 to 0.17)]
(Table 3). The additional adjustments for change in heart
rate between ages 60–64 and 36, lifetime smoking, drinking
and physical activity status had little impact on the associ-
ation (Table 3, Model 4). A similar pattern was observed for
DBP (data not shown), with the inverse association largely
attenuated by change in BMI between ages 60–64 and
36 years and marginally by the other behavioural changes
across adulthood.
Third, we additionally adjusted our main analyses by
antidepressant medications at age 60–64 and found the
associations to be close to those reported in the main
analyses in Model 5: lower SBP in study members with
case-level affective symptoms at one to two time-points
(1.65mmHg; 95% CI 3.57 to 0.28) and at three to four
time-points (3.57mmHg; 95% CI 6.85 to 0.28), com-
pared with those never meeting case criteria (P value for
trend 0.048).
Fourth, we expanded our definition of caseness of
anxiety and depression by including any participant who
reported use of antidepressant medications at each time
point, thus increasing the frequency of affective caseness.
In analyses adjusted for all covariates, as in Model 5, we
found a similar pattern of associations to that reported in theCopyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
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caseness at one to two time-points (n¼ 476) (1.54mmHg;
95% CI 3.47 to 0.39) and at three to four time-points
(n¼ 179) (3.63mmHg; 95% CI6.46 to0.79), compared
with those never meeting case criteria (n¼ 1028) (P value
for trend 0.027).
Fifth, we excluded study members using antihyperten-
sive medications from the analyses (remained n¼ 1121)
and found the associations to be close to those reported in
the main analysis in Model 5: lower systolic BP in study
members with case-level affective symptoms at one to two
time-points (n¼ 293) (2.28mmHg; 95% CI 4.58 to 0.02)
and at three to four time-points (n¼ 79) (3.32mmHg; 95%
CI 7.32 to 0.67), compared with those never meeting case
criteria (n¼ 749) (P value for trend 0.06).
Finally, when we added 10mmHg to SBP for individuals
who used antihypertensive medications, we found the
associations to be close to those reported in the main
analysis in Model 5: lower SBP in study members with
case-level affective symptoms at one to two time-points
(1.11mmHg; 95% CI 3.12 to 0.90) and at three to four
time-points (3.84mmHg; 95% CI 7.27 to 0.41), com-
pared with those never meeting case criteria (P value for
trend 0.07).
DISCUSSION
In a nationally representative British population, evidence
was found of a cumulative inverse effect of anxiety and
depression across adulthood on SBP in early old age,
although no association was found between caseness of
anxiety and depression and hypertension. These associ-
ations were robust to adjustment for a range of potential
confounding factors and mediators and were not explained
by use of antidepressant or antihypertensive medication.
Together, these findings contradict the hypothesis that the
well established association between depression and CVD
might be explained by elevated BP [37]. However, the results
of low SBP with respect to symptoms of anxiety and depres-
sion support other large population-based studies findings
[8,9,20] and extend the existing literature by providing
evidence of the cumulative effect of anxiety and depression
on BP levels across four follow-up examinations.
Recently, Hildrum et al. [9] reported changes in mean
SBP from baseline to year 22 and from year 11 to year 22
with a stronger decrease in SBP in individuals with a high
affective symptom level at all three examinations compared
with individuals with a lower symptom level in a fully
adjusted model. This is in line with our fully adjusted
findings even though our outcome (BP level at age
60–64 compared with change in BP value) and our statis-
tical approach were different. Indeed, we were able to
demonstrate a cumulative effect of anxiety and depression
across adulthood on SBP level.
In another recent study based on the British Whitehall II
study, Nabi et al. [12] observed an increased risk of hyper-
tension in later life in men with repeated experience of
symptoms of anxiety and depression over time. This at first
appears to be the opposite of our own findings. However,
they observed a lower risk of hypertension before 55 years
in both men andwomen in the increasing depression groupCopyright © Lippincott Williams & Wilkins. Unaut
1596 www.jhypertension.comcomparedwith those in the low/transient group (24% lower
risk at ages 35–39).
In a recent article by Shah et al. [21], sex and age
differences were observed in the association between
depressive symptoms and BP as a continuous trait. Women
and older adults with greater depressive symptoms were at
an increased risk of elevated SBP compared with those
with fewer depressive symptoms. However, opposite
results were observed in men, in line with our findings
even though we did not observe sex differences.
Other studies with contradictory or nonsignificant find-
ings are hard to interpret and to compare due to the use of
self-reported hypertension instead of direct measurement
of BP [11,15,16], a short period of follow-up [16] and a
possible mediating role of tricyclic antidepressants [16]. It is
unlikely that our results were biased by the use of anti-
hypertensive medications or antidepressants. Antidepress-
ant medications might, in fact, be expected to increase SBP
[6], and in our analysis, the association persisted after
adjustment for these. Furthermore, it may be argued that
study members with case-level affective symptoms at
three to four time-points had lower SBP due to better
antihypertensive treatment. Indeed, we observed that at
age 60–64, those with affective symptoms were more likely
to be treated (38.8 versus 30.6%) and had a better BP control
(24.8 versus 15.2% controlled hypertensive) than the study
members never meeting case criteria. However, our sensi-
tivity analyses showed that the inverse association persisted
after excluding individuals using antihypertensive medi-
cations.
The potential mechanism between symptoms of anxiety
and depression and lower SBP is a matter of speculation.
The neuropeptide Y and related peptides might be
involved. Cerebrospinal fluid levels of those neuropeptides
have been found to be inversely associated with anxiety
scores in depressed patients [38]. These peptides seem to be
associated with several mental symptoms and disorders, to
suppress sympathetic activity and to decrease BP [39].
Another possible explanation for the association of chronic
elevated symptom levels of anxiety/depression with lower
BP might be the dysregulation of cortisol secretion [40].
Cortisol plays a major role on the regulation of vascular
tone. In recent studies, lower cortisol levels have been
observed in depressed patients, possibly indicating a sign
of exhaustion of the hypothalamic-pituitary-adrenal (HPA)
axis, after chronic and recurrent depressive episodes
[41–43]. A possible mechanism for hypocortisolism is
downregulation of corticotrophin-releasing factor (CRH)
receptors in the pituitary, following a longer period of
stress-induced hypothalamic CRH secretion, resulting in
lower adrenocorticotropic hormone (ACTH) and reduced
cortisol levels [44]. Alternatively, reduced biosynthesis or
depletion of CRH, ACTH and/or cortisol or increased
sensitivity of the HPA-axis to negative feedback [44,45]
could play a role in hypocortisolism.
The main strength of the present study is the prospective
collection of information on symptoms of anxiety and
depression at multiple times across adulthood. Indeed,
in a recent meta-analysis, Meng et al. [14] showed that
the association of depression with hypertension risk
depends on the follow-up duration. In the cohorts withhorized reproduction of this article is prohibited.
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Blood pressure and depression across adulthoodshort follow-up duration, depression contributed a little to
hypertension risk, whereas in the cohorts with longer
follow-up duration, depression had a positive association
with hypertension risk. Therefore, the authors recom-
mended a minimum of 5-year follow-up to show whether
there is any effect of psychological factors on hypertension
[14]. Moreover, other authors emphasized the importance
of repeated assessments when evaluating the effect of
mental distress on BP due to the fluctuation of symptoms
of anxiety and depression over time [12,13,21]. The increas-
ing number of assessments provides a more precise
exposure measure. It seems reasonable that ongoing
symptoms of anxiety and depression have stronger long-
term physiological effects than a shorter period of mental
distress.
Another strength is that the association between case-
level affective symptoms across adulthood and lower SBP
remained after the adjustment for most of the potential
confounders and mediators. Two confounders, sex and
BMI, had a large impact on the estimates, whereas other
confounders such as educational attainment, socioeco-
nomic position, history of CVD and diabetes mellitus did
not. The potential mediators such as heart rate and lifestyle
behaviours had a little impact on the association, even
taking into account their changes across adulthood.
Study limitations include potential residual confounding
due to the information bias in the collection of risk behav-
iours or to their use as a binary variable (although that was
necessary to define longitudinal health behaviour due to
small numbers in certain categories), the use of different
measures of caseness of anxiety and depression over time,
and the difficulty of assessing the independent effects of
anxiety and depression on BP because of the different
assessment of symptoms of anxiety and depression at
different time points. However, several authors have
observed notable neurobiological, psychological and psy-
chometric overlap between anxiety and depression [46,47]
and Hildrum et al. [9] found that anxiety and depression
each contributed to the lowering of BP.
The NSHD cohort was established using a sampling
frame that ensured that it was nationally representative
of the population born in England, Scotland and Wales in
1946. Since then, losses to follow-up due to death, emi-
gration, loss of contact and permanent refusal have
occurred. Despite this, at age 60–64 years, the sample
remained representative of the national population born
at a similar time [23]. Our frequency of affective symptom
caseness (17.7%) was in-between that reported for com-
mon mental disorder in the UK Psychiatric Morbidity
Survey [48] for age 55–64 years (14.1%) and that reported
in a recent meta-analysis based on the GHQ used at UK
population level [49]. Moreover, Stafford et al. [23] have
shown that in NSHD, psychological distress at the prior
sweep and mental health profiles across several previous
sweeps were not associated with response rates at age
60–64.
From the 2216 people with at least one valid outcome
measure, 533 were excluded from analyses because of
missing data on covariates. When the characteristics of
those excluded were compared with those included,
there were no differences in the distributions of mostCopyright © Lippincott Williams & Wilkins. Unauth
Journal of Hypertensionkey characteristics (supplementary Table 4, http://links.
lww.com/HJH/A361). However, those excluded were more
likely to have lower educational level and lower socio-
economic position, to be current smokers and nondrinkers,
and to have higher prevalence of CVD than those included.
It is not expected that these differences would introduce a
substantial bias, as the adjustment by those covariates had a
little impact on the association between case-level affective
symptoms and BP. In the sample under investigation, the
frequency of hypertension was slightly underestimated
compared with those excluded. However, comparing
excluded and included study members, there was no
difference in the frequency of hypertension across lifetime
affective caseness groups.
In conclusion, our results suggest that there is a cumu-
lative inverse effect of case-level affective symptoms across
adulthood on SBP in early old age, and that this association
remains after controlling for potential confounders and
mediators. Mechanisms by which mood may impact BP
are poorly understood and population research should
now focus on teasing out potential causal pathways.
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